A citation-based method for searching scientific literature

Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Michael Berry, Saundra S Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E Garber, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison Kurian, Jennifer K Litton, Lisa Madlensky, P Kelly Marcom, Sofia D Merajver, Kenneth Offit, Tuya Pal, Huma Rana, Gwen Reiser, Mark E Robson, Kristen Mahoney Shannon, Elizabeth Swisher, Nicoleta C Voian, Jeffrey N Weitzel, Alison Whelan, Myra J Wick, Georgia L Wiesner, Mary Dwyer, Rashmi Kumar, Susan Darlow. J Natl Compr Canc Netw 2016
Times Cited: 111



Stephen E Lincoln, Yuya Kobayashi, Michael J Anderson, Shan Yang, Andrea J Desmond, Meredith A Mills, Geoffrey B Nilsen, Kevin B Jacobs, Federico A Monzon, Allison W Kurian, James M Ford, Leif W Ellisen. J Mol Diagn 2015
Times Cited: 111




List of shared articles



Times cited

Economic impact of multigene panel testing for hereditary breast and ovarian cancer.
Stacey Dacosta Byfield, Helen Wei, Mary DuCharme, Johnathan M Lancaster. J Comp Eff Res 2021
0

Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.
Iulian Gabriel Goidescu, Gabriela Caracostea, Dan Tudor Eniu, Florin Vasile Stamatian. Clujul Med 2018
4

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
Kristina G Flores, Laurie E Steffen, Christopher J McLouth, Belinda E Vicuña, Amanda Gammon, Wendy Kohlmann, Lucretia Vigil, Zoneddy R Dayao, Melanie E Royce, Anita Y Kinney. J Genet Couns 2017
8

Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.
Yuya Kobayashi, Shan Yang, Keith Nykamp, John Garcia, Stephen E Lincoln, Scott E Topper. Genome Med 2017
87

The use of panel testing in familial breast and ovarian cancer.
Matina Prapa, Joyce Solomons, Marc Tischkowitz. Clin Med (Lond) 2017
4